InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,616.33
(
-0.32%
)
US TECH 100
19,011.60
(
-0.98%
)
Dow Jones
41,217.51
(
0.10%
)
Brent Oil
80.48
(
2.68%
)
Bitcoin
63,615.33
(
-1.16%
)
Post# of 252975
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

cesrph09

Send PM Follow Ignore
Followers 0
Posts 160
Boards Moderated 0
Alias Born 07/18/2006

cesrph09

Re: None

Saturday, 06/09/2007 4:28:23 PM

Saturday, June 09, 2007 4:28:23 PM

Post# of 252975
ENCY - I was wondering if anyone has been following it. It is due for FDA ruling by june 15th. GILD's version is due for ruling by June 18th. From all the reading I have done, it seems ENCY has more data, may be more effective but slightly more toxic. Both seem superior to Tracleer. I was wondering how other people were interpreting the data and what they were expecting the FDA to do. I think ENCY gets approved on the condition of post marketing studies. GILD will get approvable unless they pay off the FDA.

TIA
CES

"It is what it is."

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up